Skip to main content
SpringerLink
Log in

Drug-Induced Parkinsonism in the Aged

Recognition and Prevention

  • Review Article
  • Adverse Reactions
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Drug-induced Parkinsonism is a frequent adverse effect of numerous drugs interfering with dopamine function at the basal ganglionic level. It accounts for 4% of all patients with Parkinsonism seen in neurology clinics. Pharmacological agents implicated in the production of this disorder have a wide range of applications in medicine, beyond the treatment of psychiatric illnesses. Antipsychotics, substituted benzamides and calcium channel blockers are the drugs most commonly involved.

The aged population is at an increased risk of drug-induced Parkinsonism due to intrinsic factors and because they often receive multiple drugs, including those from self-medication. Lack of knowledge in the medical profession of the potential hazards involved in the use of certain drugs plays a contributory role in the development of drug-induced Parkinsonism. Physicians should be always alert in order to detect, as early as possible, the presence of extrapyramidal symptoms in patients exposed to medications with antidopaminergic properties.

Whenever possible, withdrawal of the medication will help resolve symptoms; complete remission takes place within 6 to 18 months in the majority of patients. The use of anti-Parkinsonian drugs is only advisable if the symptomatology is disabling. The best available treatment is prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stacy M, Jankovic J. Differential diagnosis of Parkinson’s disease and the Parkinsonism plus syndromes. Neurol Clin 1992; 10: 341–5

    PubMed  CAS  Google Scholar 

  2. McCreadie RG. The Nithsdale schizophrenia surveys: an overview. Soc Psychiatry Psychiatr Epidemiol 1992; 27(1): 40–5

    Article  PubMed  CAS  Google Scholar 

  3. Weiner WJ, Lang AE. Drug-induced movement disorders. In: Weiner WJ, Lang AE, editors. Movement disorders: a comprehensive survey. New York: Futura, 1989: 599–644

    Google Scholar 

  4. McCreadie RG, Hall DJ, Berry IJ, et al. The Nithsdale schizophrenia surveys. X: obstetric complications, family history and abnormal movements. Br J Psychiatry 1992; 160: 799–805

    Article  PubMed  CAS  Google Scholar 

  5. Gimenez Roldan S, Mateo D. Cinnarizine-induced parkinsonism susceptibility related to aging and essential tremor. Clin Neuropharmacol 1991; 14(2): 156–64

    Article  PubMed  CAS  Google Scholar 

  6. Garcia-Ruiz PJ, de Yebenes JG, Jimenez-Jimenez FJ, et al. Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neuropharmacol 1992; 15(1): 19–26

    Article  PubMed  CAS  Google Scholar 

  7. Delay J, Deniker P, Harl JM. Utilisation en therapeutique psychiatrique d’une phenothiazine d’action centrale elective (4560 RP). Ann Med Psychol (Paris) 1952; 110: 112–7

    CAS  Google Scholar 

  8. Ayd FJ. A survey of drug-induced extrapyramidal reactions. JAMA 1961; 175: 1054–60

    Article  PubMed  CAS  Google Scholar 

  9. Chivers JK, Gommeren W, Leysen JE, et al. Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J Pharm Pharmacol 1988; 40: 415–21

    Article  PubMed  CAS  Google Scholar 

  10. Montagna P, Gabellini AS, Monari L, et al. Parkinsonian syndrome after long-term treatment with clebopride. Mov Disord 1992; 7(1): 89–90

    Article  PubMed  CAS  Google Scholar 

  11. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988; 38: 391–4

    Article  PubMed  CAS  Google Scholar 

  12. Chouza C, Caamaño JL, Aljanati R, et al. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet 1986; 2: 1303–4

    Article  Google Scholar 

  13. Marti-Masso JF, Carrera N, Urtasun M. Newer drugs inducing parkinsonism. In: Ninth International Symposium on Parkinson’s Disease: book of abstracts. 1988 Jun 5–9; Jerusalem. Jerusalem, 1988: 137

  14. Marti-Masso JF, Carrera N, Urtasun M. Drug-Induced Parkinsonism: a growing list [letter]. Mov Disord 1993; 8(1): 125

    Article  PubMed  CAS  Google Scholar 

  15. Wiseman LR, Faulds D. Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116–52

    Article  PubMed  CAS  Google Scholar 

  16. Laporte JR, Capeila D. Useless drugs are not placebos: lessons from flunarizine and cinnarizine. Lancet 1986; 1: 853–4

    Article  Google Scholar 

  17. Garcia Ruiz PJ, Mena MA, Penafiel N, et al. Cinnarizineinduced parkinsonism in primates. Clin Neuropharmacol 1992; 15(2): 152–4

    Article  PubMed  CAS  Google Scholar 

  18. Stephen PJ, Williamson J. Drug-induced Parkinsonism in the elderly. Lancet 1984; 2: 1082–3

    Article  PubMed  CAS  Google Scholar 

  19. Yassa R, Lal S. Prevalence of the rabbit syndrome. Am J Psychiatry 1986; 143: 656–7

    PubMed  CAS  Google Scholar 

  20. Gershanik, O. Drug-induced movement disorders. Curr Opin Neurol Neurosurg 1993; 6(3): 369–76

    PubMed  CAS  Google Scholar 

  21. Melamed E, Achiron A, Shapira A, et al. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome. Clin Neuropharmacol 1991; 14(3): 273–8

    Article  PubMed  CAS  Google Scholar 

  22. Bersani G, Grispini A, Marini S, et al. 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. Clin Neuropharmacol 1990; 13(6): 500–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Seccion Enfermedades Extrapiramidales, Centro Neurologico-Hospital Frances, La Rioja 951 (1221), Buenos Aires, Argentina

    Oscar S. Gershanik

Authors
  1. Oscar S. Gershanik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gershanik, O.S. Drug-Induced Parkinsonism in the Aged. Drugs & Aging 5, 127–132 (1994). https://doi.org/10.2165/00002512-199405020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199405020-00006

Keywords

Search

Navigation